Gelatide is the subject of a newly released 2026 informational consumer evaluation detailing the marketing claims, ingredient ...
FDA authorization covers platinum-resistant disease after 1–3 prior lines, with mandatory prior bevacizumab exposure, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results